Immunology - New study could prevent T cell exhaustion in the immune system’s fight against cancer
Can't see this email? View it online
   
  Immunology  
  The latest immunology news from News Medical  
 

Aging immune cells increase risk for macular degeneration8 Tips for Ensuring a Successful ELISA

The enzyme-linked immunosorbent assay (ELISA) is a fundamental application in diagnostic and biomedical research labs. Its success relies on careful technique, sound experimental design, and proper controls. Learn quick technical tips from experts to optimize your ELISA workflow, including how to:

  • Select the right ELISA kit
  • Avoid contamination
  • Normalize data
Download the free guide now
 
   New study could prevent T cell exhaustion in the immune system’s fight against cancerNew study could prevent T cell exhaustion in the immune system’s fight against cancer
 
In a new study, scientists from La Jolla Institute for Immunology (LJI) explain that T cells can be designed to eliminate tumors without succumbing to T cell exhaustion. The study has been published in Nature Immunology.
 
   Researchers develop repository showcasing antibody activity on spike protein variantsResearchers develop repository showcasing antibody activity on spike protein variants
 
Scientists have created an “atlas” that charts how 152 different antibodies attack a major piece of the SARS-CoV-2 machinery, the spike protein.
 
   Researchers isolate human monoclonal antibodies that may neutralize several norovirus variantsResearchers isolate human monoclonal antibodies that may neutralize several norovirus variants
 
Researchers at Vanderbilt University Medical Center and the Baylor College of Medicine in Houston, Texas, have taken a big step toward developing targeted treatments and vaccines against a family of viruses that attacks the gastrointestinal tract.
 
   Monoclonal antibody CT-P59 demonstrates potent antiviral efficacy against SARS-CoV-2 delta variantMonoclonal antibody CT-P59 demonstrates potent antiviral efficacy against SARS-CoV-2 delta variant
 
A Korean study has recently demonstrated antiviral potency of monoclonal antibody CT-P59 against the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The experiments conducted in animals infected with the delta variant have shown that CT-P59 is able to reduce symptom intensity and viral replication in the respiratory tract. The study is currently available on the bioRxiv* preprint server.